Debt-to-equity of Yubo International Biotech Ltd from 30 Sep 2021 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Yubo International Biotech Ltd quarterly Debt-to-equity in % history and change rate from 30 Sep 2021 to 30 Sep 2025.
  • Yubo International Biotech Ltd Debt-to-equity for the quarter ending 30 Sep 2025 was -135%, a 19% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Yubo International Biotech Ltd Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 -135% +32% +19% 30 Sep 2025
Q2 2025 -136% +53% +28% 30 Jun 2025
Q1 2025 -145% +70% +32% 31 Mar 2025
Q4 2024 -155% +100% +39% 31 Dec 2024
Q3 2024 -167% +161% +49% 30 Sep 2024
Q2 2024 -189% +226% +54% 30 Jun 2024
Q1 2024 -215% +254% +54% 31 Mar 2024
Q4 2023 -255% +296% +54% 31 Dec 2023
Q3 2023 -328% +373% +53% 30 Sep 2023
Q2 2023 -416% +593% +59% 30 Jun 2023
Q1 2023 -469% +17326% +97% 31 Mar 2023
Q4 2022 -551% -1524% -157% 31 Dec 2022
Q3 2022 -701% -1116% -269% 30 Sep 2022
Q2 2022 -1009% 30 Jun 2022
Q1 2022 -17795% 31 Mar 2022
Q4 2021 973% 31 Dec 2021
Q3 2021 416% 30 Sep 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.